 | • レポートコード：D0GIR-00925 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：New Technology |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、新型コロナウイルス感染症診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。新型コロナウイルス感染症診断の種類別市場規模（RT-PCR、等温核酸増幅、その他）、用途別市場規模（病院、検査室）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Cepheid、Microsens Dx、Abbott、Mesa Biotech、Credo、GenMark Diagnostics ・地域別グローバル市場分析 2015年-2020年 ・新型コロナウイルス感染症診断の北米市場（アメリカ、カナダ、メキシコ） ・新型コロナウイルス感染症診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・新型コロナウイルス感染症診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・新型コロナウイルス感染症診断の南米市場（ブラジル、アルゼンチン） ・新型コロナウイルス感染症診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：RT-PCR、等温核酸増幅、その他 ・用途別分析：病院、検査室 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The COVID-19 Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global COVID-19 Diagnosis sales will be xx in 2020 from COVID-19 Diagnosis million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global COVID-19 Diagnosis market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the COVID-19 Diagnosis industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on COVID-19 Diagnosis and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
COVID-19 Diagnosis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, COVID-19 Diagnosis market has been segmented into:
RT-PCR
Isothermal Nucleic Acid Amplification
Others
By Application, COVID-19 Diagnosis has been segmented into:
Hospital
Laboratory
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global COVID-19 Diagnosis market presented in the report. This section sheds light on the sales growth of different regional and country-level COVID-19 Diagnosis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global COVID-19 Diagnosis market.
The report offers in-depth assessment of the growth and other aspects of the COVID-19 Diagnosis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and COVID-19 Diagnosis Market Share Analysis
COVID-19 Diagnosis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, COVID-19 Diagnosis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the COVID-19 Diagnosis sales, revenue and market share for each player covered in this report.
The major players covered in COVID-19 Diagnosis are:
Cepheid
Microsens Dx
Abbott
Mesa Biotech
Credo
GenMark Diagnostics
Among other players domestic and global, COVID-19 Diagnosis market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 COVID-19 Diagnosis Market Overview
1.1 Product Overview and Scope of COVID-19 Diagnosis
1.2 Classification of COVID-19 Diagnosis by Type
1.2.1 Global COVID-19 Diagnosis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global COVID-19 Diagnosis Revenue Market Share by Type in 2019
1.2.3 RT-PCR
1.2.4 Isothermal Nucleic Acid Amplification
1.2.5 Others
1.3 Global COVID-19 Diagnosis Market by Application
1.3.1 Overview: Global COVID-19 Diagnosis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Laboratory
1.4 Global COVID-19 Diagnosis Market by Regions
1.4.1 Global COVID-19 Diagnosis Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of COVID-19 Diagnosis (2015-2025)
1.4.3 North America (USA, Canada and Mexico) COVID-19 Diagnosis Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) COVID-19 Diagnosis Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) COVID-19 Diagnosis Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) COVID-19 Diagnosis Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) COVID-19 Diagnosis Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: COVID-19 Diagnosis Industry Impact
1.5.1 COVID-19 Potential Implications for the COVID-19 Diagnosis
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on COVID-19 Diagnosis
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Cepheid
2.1.1 Cepheid Details
2.1.2 Cepheid Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Cepheid SWOT Analysis
2.1.4 Cepheid Product and Services
2.1.5 Cepheid COVID-19 Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.2 Microsens Dx
2.2.1 Microsens Dx Details
2.2.2 Microsens Dx Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Microsens Dx SWOT Analysis
2.2.4 Microsens Dx Product and Services
2.2.5 Microsens Dx COVID-19 Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott SWOT Analysis
2.3.4 Abbott Product and Services
2.3.5 Abbott COVID-19 Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.4 Mesa Biotech
2.4.1 Mesa Biotech Details
2.4.2 Mesa Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Mesa Biotech SWOT Analysis
2.4.4 Mesa Biotech Product and Services
2.4.5 Mesa Biotech COVID-19 Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.5 Credo
2.5.1 Credo Details
2.5.2 Credo Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Credo SWOT Analysis
2.5.4 Credo Product and Services
2.5.5 Credo COVID-19 Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.6 GenMark Diagnostics
2.6.1 GenMark Diagnostics Details
2.6.2 GenMark Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GenMark Diagnostics SWOT Analysis
2.6.4 GenMark Diagnostics Product and Services
2.6.5 GenMark Diagnostics COVID-19 Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global COVID-19 Diagnosis Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 COVID-19 Diagnosis Players Market Share
3.2.2 Top 10 COVID-19 Diagnosis Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global COVID-19 Diagnosis Revenue and Market Share by Regions
4.2 North America COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
4.3 Europe COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
4.5 South America COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
5 North America COVID-19 Diagnosis Revenue by Countries
5.1 North America COVID-19 Diagnosis Revenue by Countries (2015-2020)
5.2 USA COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
5.3 Canada COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
5.4 Mexico COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
6 Europe COVID-19 Diagnosis Revenue by Countries
6.1 Europe COVID-19 Diagnosis Revenue by Countries (2015-2020)
6.2 Germany COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
6.3 UK COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
6.4 France COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
6.5 Russia COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
6.6 Italy COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
7 Asia-Pacific COVID-19 Diagnosis Revenue by Countries
7.1 Asia-Pacific COVID-19 Diagnosis Revenue by Countries (2015-2020)
7.2 China COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
7.3 Japan COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
7.4 Korea COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
7.5 India COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
8 South America COVID-19 Diagnosis Revenue by Countries
8.1 South America COVID-19 Diagnosis Revenue by Countries (2015-2020)
8.2 Brazil COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
8.3 Argentina COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue COVID-19 Diagnosis by Countries
9.1 Middle East & Africa COVID-19 Diagnosis Revenue by Countries (2015-2020)
9.2 Saudi Arabia COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
9.3 UAE COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
9.4 Egypt COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
9.5 South Africa COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global COVID-19 Diagnosis Revenue and Market Share by Type (2015-2020)
10.2 Global COVID-19 Diagnosis Market Forecast by Type (2019-2024)
10.3 RT-PCR Revenue Growth Rate (2015-2025)
10.4 Isothermal Nucleic Acid Amplification Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global COVID-19 Diagnosis Market Segment by Application
11.1 Global COVID-19 Diagnosis Revenue Market Share by Application (2015-2020)
11.2 COVID-19 Diagnosis Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Laboratory Revenue Growth (2015-2020)
12 Global COVID-19 Diagnosis Market Size Forecast (2021-2025)
12.1 Global COVID-19 Diagnosis Market Size Forecast (2021-2025)
12.2 Global COVID-19 Diagnosis Market Forecast by Regions (2021-2025)
12.3 North America COVID-19 Diagnosis Revenue Market Forecast (2021-2025)
12.4 Europe COVID-19 Diagnosis Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific COVID-19 Diagnosis Revenue Market Forecast (2021-2025)
12.6 South America COVID-19 Diagnosis Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa COVID-19 Diagnosis Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global COVID-19 Diagnosis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of COVID-19 Diagnosis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global COVID-19 Diagnosis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market COVID-19 Diagnosis Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global COVID-19 Diagnosis Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Cepheid Corporate Information, Location and Competitors
Table 7. Cepheid COVID-19 Diagnosis Major Business
Table 8. Cepheid COVID-19 Diagnosis Total Revenue (USD Million) (2017-2018)
Table 9. Cepheid SWOT Analysis
Table 10. Cepheid COVID-19 Diagnosis Product and Solutions
Table 11. Cepheid COVID-19 Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Microsens Dx Corporate Information, Location and Competitors
Table 13. Microsens Dx COVID-19 Diagnosis Major Business
Table 14. Microsens Dx COVID-19 Diagnosis Total Revenue (USD Million) (2018-2019)
Table 15. Microsens Dx SWOT Analysis
Table 16. Microsens Dx COVID-19 Diagnosis Product and Solutions
Table 17. Microsens Dx COVID-19 Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Abbott Corporate Information, Location and Competitors
Table 19. Abbott COVID-19 Diagnosis Major Business
Table 20. Abbott COVID-19 Diagnosis Total Revenue (USD Million) (2017-2018)
Table 21. Abbott SWOT Analysis
Table 22. Abbott COVID-19 Diagnosis Product and Solutions
Table 23. Abbott COVID-19 Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Mesa Biotech Corporate Information, Location and Competitors
Table 25. Mesa Biotech COVID-19 Diagnosis Major Business
Table 26. Mesa Biotech COVID-19 Diagnosis Total Revenue (USD Million) (2017-2018)
Table 27. Mesa Biotech SWOT Analysis
Table 28. Mesa Biotech COVID-19 Diagnosis Product and Solutions
Table 29. Mesa Biotech COVID-19 Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Credo Corporate Information, Location and Competitors
Table 31. Credo COVID-19 Diagnosis Major Business
Table 32. Credo COVID-19 Diagnosis Total Revenue (USD Million) (2017-2018)
Table 33. Credo SWOT Analysis
Table 34. Credo COVID-19 Diagnosis Product and Solutions
Table 35. Credo COVID-19 Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. GenMark Diagnostics Corporate Information, Location and Competitors
Table 37. GenMark Diagnostics COVID-19 Diagnosis Major Business
Table 38. GenMark Diagnostics COVID-19 Diagnosis Total Revenue (USD Million) (2017-2018)
Table 39. GenMark Diagnostics SWOT Analysis
Table 40. GenMark Diagnostics COVID-19 Diagnosis Product and Solutions
Table 41. GenMark Diagnostics COVID-19 Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Global COVID-19 Diagnosis Revenue (Million USD) by Players (2015-2020)
Table 43. Global COVID-19 Diagnosis Revenue Share by Players (2015-2020)
Table 44. Global COVID-19 Diagnosis Revenue (Million USD) by Regions (2015-2020)
Table 45. Global COVID-19 Diagnosis Revenue Market Share by Regions (2015-2020)
Table 46. North America COVID-19 Diagnosis Revenue by Countries (2015-2020)
Table 47. North America COVID-19 Diagnosis Revenue Market Share by Countries (2015-2020)
Table 48. Europe COVID-19 Diagnosis Revenue (Million USD) by Countries (2015-2020)
Table 49. Asia-Pacific COVID-19 Diagnosis Revenue (Million USD) by Countries (2015-2020)
Table 50. South America COVID-19 Diagnosis Revenue by Countries (2015-2020)
Table 51. South America COVID-19 Diagnosis Revenue Market Share by Countries (2015-2020)
Table 52. Middle East and Africa COVID-19 Diagnosis Revenue (Million USD) by Countries (2015-2020)
Table 53. Middle East and Africa COVID-19 Diagnosis Revenue Market Share by Countries (2015-2020)
Table 54. Global COVID-19 Diagnosis Revenue (Million USD) by Type (2015-2020)
Table 55. Global COVID-19 Diagnosis Revenue Share by Type (2015-2020)
Table 56. Global COVID-19 Diagnosis Revenue Forecast by Type (2021-2025)
Table 57. Global COVID-19 Diagnosis Revenue by Application (2015-2020)
Table 58. Global COVID-19 Diagnosis Revenue Share by Application (2015-2020)
Table 59. Global COVID-19 Diagnosis Revenue Forecast by Application (2021-2025)
Table 60. Global COVID-19 Diagnosis Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. COVID-19 Diagnosis Picture
Figure 2. Global COVID-19 Diagnosis Revenue Market Share by Type in 2019
Figure 3. RT-PCR Picture
Figure 4. Isothermal Nucleic Acid Amplification Picture
Figure 5. Others Picture
Figure 6. COVID-19 Diagnosis Revenue Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Laboratory Picture
Figure 9. Global COVID-19 Diagnosis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America COVID-19 Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe COVID-19 Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific COVID-19 Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America COVID-19 Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa COVID-19 Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global COVID-19 Diagnosis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global COVID-19 Diagnosis Revenue Share by Players in 2019
Figure 17. Global Top 5 Players COVID-19 Diagnosis Revenue Market Share in 2019
Figure 18. Global Top 10 Players COVID-19 Diagnosis Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global COVID-19 Diagnosis Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global COVID-19 Diagnosis Revenue Market Share by Regions (2015-2020)
Figure 22. Global COVID-19 Diagnosis Revenue Market Share by Regions in 2018
Figure 23. North America COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 24. Europe COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 26. South America COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 28. North America COVID-19 Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 29. North America COVID-19 Diagnosis Revenue Market Share by Countries in 2019
Figure 30. USA COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 31. Canada COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 32. Mexico COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 33. Europe COVID-19 Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 34. Europe COVID-19 Diagnosis Revenue Market Share by Countries in 2019
Figure 35. Germany COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 36. UK COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 37. France COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 38. Russia COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 39. Italy COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific COVID-19 Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific COVID-19 Diagnosis Revenue Market Share by Countries in 2019
Figure 42. China COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 43. Japan COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 44. Korea COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 45. India COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 47. South America COVID-19 Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 48. South America COVID-19 Diagnosis Revenue Market Share by Countries in 2019
Figure 49. Brazil COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 50. Argentina COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa COVID-19 Diagnosis Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa COVID-19 Diagnosis Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 54. UAE COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 55. Egypt COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 56. South Africa COVID-19 Diagnosis Revenue and Growth Rate (2015-2020)
Figure 57. Global COVID-19 Diagnosis Revenue Share by Type (2015-2020)
Figure 58. Global COVID-19 Diagnosis Revenue Share by Type in 2019
Figure 59. Global COVID-19 Diagnosis Market Share Forecast by Type (2021-2025)
Figure 60. Global RT-PCR Revenue Growth Rate (2015-2020)
Figure 61. Global Isothermal Nucleic Acid Amplification Revenue Growth Rate (2015-2020)
Figure 62. Global Others Revenue Growth Rate (2015-2020)
Figure 63. Global COVID-19 Diagnosis Revenue Share by Application (2015-2020)
Figure 64. Global COVID-19 Diagnosis Revenue Share by Application in 2019
Figure 65. Global COVID-19 Diagnosis Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospital Revenue Growth Rate (2015-2020)
Figure 67. Global Laboratory Revenue Growth Rate (2015-2020)
Figure 68. Global COVID-19 Diagnosis Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global COVID-19 Diagnosis Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global COVID-19 Diagnosis Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America COVID-19 Diagnosis Revenue Market Forecast (2021-2025)
Figure 72. Europe COVID-19 Diagnosis Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific COVID-19 Diagnosis Revenue Market Forecast (2021-2025)
Figure 74. South America COVID-19 Diagnosis Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa COVID-19 Diagnosis Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
クラミジア診断・治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Chlamydia Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chlamydia D…- インフルエンザ診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Flu Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 自己免疫疾患診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Diagnosis of Autoimmune Diseases market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- モバイル監視診断医療機器の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Mobile Monitoring Diagnosis Medical Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- 着床前遺伝子診断（PGD）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Pre-Implantation Genetic Diagnosis (PGD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …